Skip to main content
. 2022 Jul 5;13(29):8657–8666. doi: 10.1039/d2sc02488h

Fig. 4. (a) Relative viabilities of normal 293T (left) and SKOV-3 (right) tumour cells after incubation for 24 h at different WP5⊃G concentrations. (b) CLSM images of 293T and SKOV-3 cells after being treated with WP5⊃G–siRNA for 30 min. (c) CLSM images of SKOV-3 cells after being treated with WP5⊃G-FAM–siRNA.

Fig. 4